RMM Directory - medicines starting with S

Sarclisa HCP Brochure

This brochure contains important information for HCPs & blood banks concerning the appropriate measures to manage isatuximab interference and avoid possible resulting adverse clinical consequences and to inform that isatuximab may interfere with routine blood compatibility tests with potential false positive reactions in the indirect antiglobulin test (indirect Coombs test). For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]

For Healthcare Professionals

Sarclisa Patient Alert Card

This patient alert card contains important safety information that you need to be aware of before, during, and after treatment with SARCLISA. For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]

Checklist for Healthcare Professionals

These educational materials focus on the provision of advice for the recognition of anticholinergic effects that can be associated with glycopyrronium bromide containing products and how best to manage specific events.

For Healthcare Professionals

Healthcare Professional Checklist Labels

This is a sheet of checklist labels to help record anticholinergic effects in a patient’s notes.

For Healthcare Professionals

Reminder Card for Caregivers

These educational materials focus on the provision of advice for the recognition of anticholinergic effects that can be associated with glycopyrronium bromide containing products and how best to manage specific events.

Patient's Guide to Siklos

This Siklos Patient Guide contains important information about your treatment, or your child's treatment including advice on preparation and administration of your medicine, disease symptoms, and side effects.

Physicians Guide to Siklos

This Physician Guide for Siklos contains important recommendations for patient monitoring, dosage adjustments, and the management of serious adverse effects.

For Healthcare Professionals

Simponi (Golimumab): Patient Remider Card

The provision of this card to patients is required by the terms of the Marketing Authorisation. Please ensure that you carry this card with you at all times and that you have read and understood this information as it contains important safety information that you need to be aware of before, during and after treatment with golimumab.

Healthcare Professional Guideline - Important safety information for Skilarence (dimethyl fumarate)

This guideline is intended to inform HCPs about the risk of serious infections, mainly opportunistic infections such as progressive multifocal leukoencephalopathy (PML), associated with the use of Skilarence and to provide guidance on how to minimise and manage this risk through appropriate monitoring of lymphocyte and leukocyte count abnormalities.

For Healthcare Professionals

Valproate - Annual Risk Acknowledgement Form

Patient Risk Acknowledgement Form

Valproate - warning labels

Warning Labels for Cartons

Valproate - HCP Guide

Guide about use of valproate in pregnancy

For Healthcare Professionals

Valproate - Patient Guide

Guide on use of of valproate during pregnancy

Valproate- Patient Reminder Card

Patient Reminder Card

Valproate - Poster

Warning Poster

For Healthcare Professionals

Combined hormonal contraceptives: Checklist for Prescribers

For Healthcare Professionals

Combined hormonal contraceptives: Important information for women

Combined hormonal contraceptives: Important information for women about the risk of blood clots

Soliris Patient Safety Card

Important Safety Information for Patients Receiving Soliris® Show this card to any doctor involved in your care.

Soliris Patient/Parent Information

This guide is for adult patients and parents/legal guardians of a child who has been prescribed eculizumab. The guide provides you with important safety information that you must be aware of.

Soliris Physician's Guide

The aim of this brochure is to educate and/or remind healthcare professionals about the selected prevention measures, detection, careful monitoring and/or proper management of selected safety concerns associated with eculizumab.

For Healthcare Professionals

Injection Guide - Parent / Caregivers with Infant Patients

This Injection Guide is for the parents and caregivers of infant patients with paediatric-onset hypophosphatasia who would benefit from long-term enzyme replacement therapy and have been prescribed Strensiq®. The guide gives detailed instructions, with clear diagrams, on how to choose the injection site and how to carry out and record the injection of your infant or child. This guide is designed as a support document to the training given by your healthcare professional. Please contact your healthcare professional if you have any questions.

Self-Injection Guide

This Self-Injection Guide is for patients with paediatric- onset hypophosphatasia who would benefit from long-term enzyme replacement therapy and have been prescribed Strensiq®. The guide gives detailed instructions, with clear diagrams, on how to choose your injection site and how to carry out and record your injection. This guide is designed as a support document to the training given by your healthcare professional. Please contact your healthcare professional if you have any questions.

Risk Minimisation Materials

Search for Risk Minimisation Materials

Sarclisa

Sanofi Genzyme

Sialanar

Proveca Limited

Siklos

Masters Pharmaceuticals Ltd

Simponi

Merck Sharp & Dohme Limited

Skilarence

Almirall Limited

Sodium valproate

Wockhardt UK Ltd

Sofiperla

Accord-UK Ltd

Soliris

Alexion Pharma UK Ltd

Strensiq

Alexion Pharma UK Ltd

Strontium ranelate

Aristo Pharma Limited

Suliqua

SANOFI

Syonell

Lupin Healthcare (UK) Ltd